DUCTAL ADENOCARCINOMA OF THE PANCREAS
Clinical trials for DUCTAL ADENOCARCINOMA OF THE PANCREAS explained in plain language.
Never miss a new study
Get alerted when new DUCTAL ADENOCARCINOMA OF THE PANCREAS trials appear
Sign up with your email to follow new studies for DUCTAL ADENOCARCINOMA OF THE PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus therapy aims to boost chemo in tough pancreatic cancer
Disease control Recruiting nowThis trial tests whether a virus called VCN-01, given more frequently, is safe and tolerable when combined with standard chemotherapy (nab-paclitaxel and gemcitabine) for people with newly diagnosed stage IV pancreatic cancer that has spread. Participants receive up to three dose…
Matched conditions: DUCTAL ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics SL • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Tiny particles, big hope: new combo tackles tough cancers
Disease control Recruiting nowThis study tests whether injecting gadolinium-based nanoparticles (AGuIX) before precise MR-guided radiation can improve tumor control for people with centrally located lung tumors or locally advanced pancreatic cancer. About 100 participants will receive the nanoparticle injecti…
Matched conditions: DUCTAL ADENOCARCINOMA OF THE PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC